Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide)-Reference-Cited by-同舟云学术

Control of postprandial hyperglycemia by oral administration of the sea anemone mucus-derived α-amylase inhibitor (magnificamide)

Published:2023-12 Issue: Volume:168 Page:115743
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Sintsova Oksana^ORCID,Popkova Darya^ORCID,Kalinovskii Aleksandr^ORCID,Rasin Anton,Borozdina Natalya^ORCID,Shaykhutdinova Elvira,Klimovich Anna,Menshov Alexander^ORCID,Kim Natalia,Anastyuk Stanislav,Kusaykin Mikhail,Dyachenko Igor^ORCID,Gladkikh Irina,Leychenko Elena^ORCID

Funder

Russian Science Foundation

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference40 articles.

1. Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021;Ong;Lancet,2023

2. Type 2 diabetes: an epidemic disease in childhood;Aye;Curr. Opin. Pediatr.,2003

3. General aspects of diabetes mellitus;Alam;Handb. Clin. Neurol.,2014

4. Type-2 diabetes: current understanding and future perspectives;Pandey;IUBMB Life,2015

5. Hyperglycemia in acute COVID-19 is characterized by insulin resistance and adipose tissue infectivity by SARS-CoV-2;Reiterer;Cell Metab.,2021

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Convenient Synthesis of Short α-/β-Mixed Peptides as Potential α-Amylase Inhibitors;Molecules;2024-08-26

2. Promising Directions for Regulating Signaling Pathways Involved in the Type 2 Diabetes Mellitus Development (A Review);Russian Journal of Bioorganic Chemistry;2024-08

3. Natural Inhibitors of Mammalian α-Amylases as Promising Drugs for the Treatment of Metabolic Diseases;International Journal of Molecular Sciences;2023-11-20